Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Assets: 2015-2024

Historic Assets for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $352.2 million.

  • Wave Life Sciences' Assets fell 32.67% to $241.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $241.4 million, marking a year-over-year decrease of 32.67%. This contributed to the annual value of $352.2 million for FY2024, which is 28.10% up from last year.
  • Latest data reveals that Wave Life Sciences reported Assets of $352.2 million as of FY2024, which was up 28.10% from $274.9 million recorded in FY2023.
  • Wave Life Sciences' 5-year Assets high stood at $352.2 million for FY2024, and its period low was $146.4 million during FY2022.
  • Its 3-year average for Assets is $257.8 million, with a median of $274.9 million in 2023.
  • Per our database at Business Quant, Wave Life Sciences' Assets decreased by 29.28% in 2022 and then skyrocketed by 87.82% in 2023.
  • Yearly analysis of 5 years shows Wave Life Sciences' Assets stood at $279.2 million in 2020, then fell by 25.87% to $207.0 million in 2021, then dropped by 29.28% to $146.4 million in 2022, then surged by 87.82% to $274.9 million in 2023, then rose by 28.10% to $352.2 million in 2024.